Home > Insider Trading > Filing (0000899243-18-019313)

Filing Details

Accession Number:: 0000899243-18-019313
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-07-03 18:23:58
Reporting Period:: 2018-06-25

Accepted Time:: 2018-07-03 18:23:58
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1314102	Eyepoint Pharmaceuticals Inc.	EYPT	Laboratory Analytical Instruments (3826)	262774444

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1612343	Ew Healthcare Partners, L.p.	21 Waterway Avenue, Suite 225 The Woodlands TX 77380	No	No	Yes	No
1652285	Essex Woodlands Fund Ix-Gp, L.p.	21 Waterway Avenue, Suite 225 The Woodlands TX 77380	No	No	Yes	No
1652286	Essex Woodlands Ix, Llc	21 Waterway Avenue, Suite 225 The Woodlands TX 77380	No	No	Yes	No
1736240	Ew Healthcare Partners-A, L.p.	21 Waterway Avenue, Suite 225 The Woodlands TX 77380	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $0.001 Par Value	Acquisiton	2018-06-25	16,211,822	$1.27	25,470,390	No	4	P	Direct
Common Stock, $0.001 Par Value	Acquisiton	2018-06-25	652,244	$1.27	25,470,390	No	4	P	Indirect	EW Healthcare Partners-A L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Indirect	EW Healthcare Partners-A L.P.

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrant	Acquisiton	2018-06-25	16,211,822	$1.27	16,211,822	$0.00
Common Stock	Warrant	Acquisiton	2018-06-25	652,244	$1.27	652,244	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
16,864,066			No	4	P	Direct
16,864,066			No	4	P	Indirect

Footnotes

The purchase price is the price of one Unit ("Unit"), with each Unit consisting of (a) one share of common stock and (b) one warrant to purchase a share of common stock.
Includes 24,485,283 shares held by EW Healthcare Partners L.P. ("EWHP") and 985,107 shares held by EW Healthcare Partners-A L.P. ("EWHP-A"). Essex Woodlands Fund IX-GP, L.P. ("Fund IX-GP") is the general partner of EWHP and EWHP-A, respectively. Essex Woodlands IX, LLC (the "General Partner") is the general partner of Fund IX-GP. The General Partner holds sole voting and dispositive power over the shares held by EWHP and EWHP-A. The managers of the General Partner are Martin P. Sutter, R. Scott Barry, Ronald Eastman (also a member of the Issuer's board of directors), Petri Vainio and Steve Wiggins (collectively, the "Managers"), and may exercise voting and investment control over the shares only by the majority action of the Managers.
The exercise price of each of the warrants will be an amount equal to the lower of (a) $1.43 or (b) a 20% discount to the volume weighted average price of the shares of Common Stock on the Nasdaq Stock Market for the 20 trading days immediately prior to the exercise of a warrant; provided, however, that the exercise price cannot be lower than $0.88.
These securities are excercisable on or prior to the fifteenth (15) business day following the date on which EWHP and EWHP-A receive notice from the Issuer that the Centers for Medicare & Medicaid Services has announced that a new C-Code has been established for DexycuTM.
Includes 16,211,864 warrant shares held by EWHP and 652,244 shares held EWHP-A. Fund IX-GP is the general partner of EWHP and EWHP-A, respectively. General Partner is the general partner of Fund IX-GP. The General Partner holds sole voting and dispositive power over the shares held by EWHP and EWHP-A. The Managers of the General Partner may exercise voting and investment control over the warrant shares only by the majority action of the Managers.